These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of parasympathetic nerves and muscarinic receptors in allergy and asthma. Scott GD; Fryer AD Chem Immunol Allergy; 2012; 98():48-69. PubMed ID: 22767057 [TBL] [Abstract][Full Text] [Related]
25. Treatment of disorders characterized by reversible airway obstruction in childhood: are anti-cholinergic agents the answer? Quizon A; Colin AA; Pelosi U; Rossi GA Curr Pharm Des; 2012; 18(21):3061-85. PubMed ID: 22564300 [TBL] [Abstract][Full Text] [Related]
26. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Julius S; Pascual AV; London R Circulation; 1971 Sep; 44(3):413-8. PubMed ID: 5097443 [No Abstract] [Full Text] [Related]
27. Characterization of the muscarinic receptors in the mesenteric vascular bed of spontaneously hypertensive rats. Hendriks MG; Pfaffendorf M; van Zwieten PA J Hypertens; 1993 Dec; 11(12):1329-35. PubMed ID: 8133015 [TBL] [Abstract][Full Text] [Related]
28. Lack of evidence for muscarinic type 2 receptor modulation of the human nasonasal reflex. deTineo ML; Clark K; Baroody FM; Naclerio RM J Allergy Clin Immunol; 2001 Jan; 107(1):194-5. PubMed ID: 11150012 [No Abstract] [Full Text] [Related]
29. Evidence for prejunctional M2 muscarinic receptors in pulmonary cholinergic nerves in the rat. Aas P; Maclagan J Br J Pharmacol; 1990 Sep; 101(1):73-6. PubMed ID: 2282469 [TBL] [Abstract][Full Text] [Related]
30. Nitric oxide and cardiac muscarinic control in humans. Chowdhary S; Marsh AM; Coote JH; Townend JN Hypertension; 2004 May; 43(5):1023-8. PubMed ID: 15037554 [TBL] [Abstract][Full Text] [Related]
31. Effects of hypoxia on atrial muscarinic cholinergic receptors and cardiac parasympathetic responsiveness. Wolfe BB; Voelkel NF Biochem Pharmacol; 1983 Jul; 32(13):1999-2002. PubMed ID: 6870928 [TBL] [Abstract][Full Text] [Related]
32. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. Panza JA; Quyyumi AA; Callahan TS; Epstein SE J Am Coll Cardiol; 1993 Apr; 21(5):1145-51. PubMed ID: 8459069 [TBL] [Abstract][Full Text] [Related]
34. Endothelial dysfunction in human essential hypertension. Mordi I; Mordi N; Delles C; Tzemos N J Hypertens; 2016 Aug; 34(8):1464-72. PubMed ID: 27203578 [TBL] [Abstract][Full Text] [Related]
35. Vascular remodeling in hypertension: mechanisms and treatment. Schiffrin EL Hypertension; 2012 Feb; 59(2):367-74. PubMed ID: 22203749 [No Abstract] [Full Text] [Related]
36. Parasympathetic innervation of rat peri-orbital smooth muscle: prejunctional cholinergic inhibition of sympathetic neurotransmission without direct postjunctional actions. Beauregard CL; Smith PG J Pharmacol Exp Ther; 1994 Mar; 268(3):1284-8. PubMed ID: 7908052 [TBL] [Abstract][Full Text] [Related]
37. Muscarinic receptors in the aortae of normo- and hypertensive rats. Manjeet S; Sim MK Jpn J Pharmacol; 1992; 58 Suppl 2():357P. PubMed ID: 1507602 [No Abstract] [Full Text] [Related]
38. Cholinergic underactivity in human memory disorders. Davis KL; Yamamura HI Life Sci; 1978 Oct; 23(17-18):1729-33. PubMed ID: 364228 [No Abstract] [Full Text] [Related]